logo
light
search

Germany Stock Screener - Compare & Analyze Key Metrics


Discover and filter top-performing stocks in the Germany market. Analyze key metrics like market cap, P/E ratio, revenue growth, and more for smarter investment decisions. Track Global Market Trends from Germany with Our Tools.

Germany Stocksarrow
clear Clear Filters

arrow

arrow

arrow

arrow

arrow

arrow

arrow

arrow

arrow

arrow

arrow

arrow

Code arrow Company Name Stock Price Sector Market Cap P/E Ratio Forward P/E Volume Return on Equity Revenue
star XETR:VMED Viromed Medical AG €2.58 - €- - - 2.06K - €-
star HM:Q11 Viromed Medical AG €2.56 - €- - - 300.00 - €-
star XBER:VMED Viromed Medical AG - €- - - 0.00 - €-
star BE:Q11 Viromed Medical AG €2.48 - €- - - 170.00 - €-
star XDUS:VMED Viromed Medical AG €1.90 - €- - - 0.00 - €-
star DU:Q11 Viromed Medical AG €2.44 Healthcare €- 0 0 200.00 0 €0.00
star FSX:VMED Viromed Medical AG €2.50 - €- - - 200.00 - €-
star STU:0VF Virtu Financial Inc €33 - €- - - 0.00 - €-
star XSTU:0VF Virtu Financial Inc. €34.20 - €- - - 0.00 - €-
star FSX:0VF Virtu Financial Inc. Financial Services €- - - - 0.37 €2.13 Billion
star XDUS:VIP Virtus Investment Partners Inc. €158 - €- - - 0.00 - €-
star FSX:VIP Virtus Investment Partners Inc. €195 Financial Services €- - - 0.00 - €-
star FSX:3V64 Visa Inc. Financial Services €- - - - 0.51 €35.14 Billion
star XDUS:3V6 Visa Inc. €20.60 - €- - - 0.00 - €-
star FSX:3V6 Visa Inc. €13.70 Financial Services €- - - 0.00 0.51 €35.14 Billion
star XSTU:3V64 Visa Inc. €312.50 - €- - - 288.00 - €-
star XBER:3V6 Visa Inc. €17.80 - €- - - 1.00 - €-
star DU:VIS Viscofan €61.80 Other €- - - 0.00 - €-
star BE:VIS Viscofan €61.40 Other €- - - 0.00 - €-
star STU:VIS Viscofan €61.70 Other €- - - 0.00 - €-

56361 - 56380 of 58545 stocks in Germany

Data Sources

Market data for Germany stocks is sourced from multiple exchanges including BA, BE, DU, F, FSX, HA, HM, MU, Munich, STU, XBER, XDUS, XETR, XETRA, XHAM, XHAN, XSTU . Our financial data is compiled from official company filings, including quarterly (10-Q) and annual (10-K) reports submitted to regulatory authorities, along with earnings releases and direct disclosures from company investor relations departments. Market prices are updated continually during trading hours, while fundamental data is refreshed daily after market close to reflect the latest financial statements and corporate actions. News and corporate events are monitored and updated in real-time to provide comprehensive coverage of market-moving developments. All financial metrics, ratios, and analysis are calculated using standardized methodologies to ensure consistency across different companies and markets.